Cell Therapeutics' Opaxio Data Not Terrible: BioBuzz
More work needs to be done before penciling in approval.
02:25PM 10/01/09
The Long Trade on Chelsea Therapeutics: BioBuzz
Risk-reward for this beaten-down stock improves as pivotal study results loom.
10:14AM 10/01/09
BioCryst Updates the Obvious: BioBuzz
The flu drug company's response to government was widely expected.
06:37AM 10/01/09
Biotech Mailbag: Biocryst, Anadys, Allos, Amag
Readers weigh in on Biocryst's flu drug, the forecast for Alzheimer's drugs, Allos' prognosis, and shy AMAG's stock is getting pummeled.
07:00AM 08/21/09
These heavily shorted stocks could soar on any positive catalyst.
10:07AM 05/20/08
Biotech Notebook: Progenics, Wyeth, Introgen
Projecting potential market share for newly approved Relistor; monitoring exec moves at Introgen; and more.
09:26AM 04/30/08
Wyeth, Elan Halt Alzheimer Drug Trial
Incidence of a skin lesion prompts the suspension of a phase II trial for their experimental vaccine ACC-001.
01:01PM 04/17/08
Top-Yielding Entertainment Stocks
These fun media stocks offer solid yeilds for shareholders.
01:12PM 04/09/08
Headwinds Threaten Aircastle's Dividend
The aircraft leasing firm's payouts are larger than its profits, and the issue could get worse as the airline industry downshifts.
01:10PM 03/18/08
Cramer: Banks Could Go the Way of the Home Lenders
Major bank failures are very possible -- that's how bad it is.
03:06PM 03/07/08
Banks Could Go the Way of the Home Lenders (RealMoney.com $)
Major bank failures are very possible -- that's how bad it is.
02:50PM 03/07/08
Insiders Don Steel Gloves in a Market of Falling Knives (RealMoney.com $)
Now is the time to 'buy it like Buffett,'but shorter-term prospects remain a crap shoot.
04:56PM 01/07/08
Don't Even Think About Financials Yet (RealMoney.com $)
This group is ripe for some major failures, and so far we haven't even seen dividend cuts.
09:44PM 01/04/08
Going bullish on Loews and bearish on Cogent, plus a look at the stocks susceptible to a tech slowdown.
08:38PM 12/29/07



Connect with TheStreet